SARAH THAYER was named the Merle M. Musselman Centennial Professor of Surgery and chief of surgical oncology at the University of Nebraska Medical Center. She was also named associate director for clinical affairs and physician-in-chief for the Fred & Pamela Buffett Cancer Center at UNMC.
In his new book, “No More Tears: The Dark Secrets of Johnson & Johnson,” Gardiner Harris, who was previously the public health and pharmaceutical business reporter for The New York Times, talks about the history of the overuse of red blood cell growth factors in oncology.
